Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer.

NPJ Precis Oncol · 2023 · PMC10576756 · PMID 37838778

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, sotigalimab combined with chemotherapy showed a trend towards an increased 1-year overall survival compared to a historical control with chemotherapy only 20 , 49 .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.